外貿協會::五金展

SCIVISION BIOTECH INC.

About us

  • Established in 2001
  • SciVision Biotech Inc. is specialized in research and development of hyaluronic-acid based medical products
  • Products are present in more than 50 countries
  • Cumulative sales reached nearly 11 million syringes

 

What we do is the best !

 

  • Patented technology : CHAP ( Cross-linked Hyaluronic Acid Products Platform)
  • Products : Dermal Filler, Viscosupplementation and Adhesion Barrier
  • SciVision has established strategic partnerships with top tier companies
  • Expanding into global markets

Products

PROTAHERE Absorbable Adhesion Barrier

Description
PROTAHERE Absorbable Adhesion Barrier is a colorless, transparent, viscoelastic, sterile and nonpyrogenic hydrogel prefilled in a plastic syringe. The product contains hyaluronic acid obtained from bacteria fermentation. The product is for single use only.

Contents
Active ingredient: Sodium Hyaluronate 40 mg / ml
Package: 6.0 mL per syringe
Package: 10.0 mL per syringe

Mode of action
The product is a viscoelastic and ductile hydrogel, which is formatted to be an adhesion of the applied tissue surface and reduce tissue adhesions after surgery. 

Indication
The product is indicated to prevent or reduce tissue adhesions after abdominopelvic surgery. 

HYAJOINT Synovial Fluid Supplement

Contents
Active ingredient: Sodium Hyaluronate 25 mg.
pH values ranging between 6.8 and 7.8
Package: 2.5 mL per glass syringe

HYAJOINT Plus Synovial Fluid Supplement

Contents
Active ingredient: Sodium Hyaluronate 60 mg.
pH values ranging between 6.8 and 7.8
Package: 3.0 mL per glass syringe

DEFEHERE Absorbable Adhesion Barrier

Description
DEFEHERE Absorbable Adhesion Barrier is a, transparent, viscous, sterile and nonpyrogenic gel supplied in a glass syringe. The product is for single-use only. The product is a bioabsorbable, extensible, auto-crosslinked hyaluronic acid gel using fermentation sourced hyaluronic acid as a major component. Hyaluronic acid is one of the main components of human connective tissue and of epithelial and mesothelial tissue. This product perfectly attaches to the tissue surface, creating anti-adhesion layer which avoids post-surgical adhesion and is completely resorbed over time.

Contents
Active ingredient: Sodium Hyaluronate 60 mg / ml
Package: 
1.0 ml per syringe
1.5 ml per syringe
2.0 ml per syringe

Mode of action
Hyaluronic acid is one of the main components of human connective tissue and of epithelial and mesothelial tissue. This product perfectly attaches to the tissue surface, creating anti-adhesion layer which avoids post-surgical adhesion and is completely resorbed over time.

Indication
The product is indicated to prevent or reduce adhesions or fibrosis following tendon and/or peripheral nerve surgery and/or surgical release of joint contractures.

FACILLE Facial Dermal Implant

Description
FACILLE fillers are clear, biodegradable and highly viscous injectable substance of hyaluronic acid in pre-filled glass syringes. Hyaluronic acid, also called hyaluronan, is the glycosaminoglycan distributed widely throughout connective tissues, dermal layers and joints. The products contain bi-phasic hyaluronic acid which are obtained from bacteria fermentation, combined with 0.3% lidocaine.

Contents
Active ingredient: Sodium Hyaluronate 20mg with Lidocaine 3mg
Package: 1.0 ml/ syringe

Indication
FACILLE facial dermal fillers are designed to correct superficial to deep wrinkle and folds of skin, improve soft tissue augmentation and shape facial contours.. The products contain lidocaine for ease discomfort and pain during filler injections.